Aadi Bioscience Competitors and Similar CompaniesClear all
Aadi Bioscience's competitors and similar companies include Omeros, HUYA Bioscience International, NMS Group and Celltrion Healthcare.
 Aadi Bioscience Aadi Bioscience is a biopharmaceutical company developing an albumin-bound mTOR inhibitor for targeted patient populations in oncology, cardiovascular, and CNS diseases. |  Omeros Omeros Corporation is a biopharmaceutical company developing products focused on inflammation and central nervous system disorders as well as immune-related diseases, including cancers. |  HUYA Bioscience International HUYA Bioscience International is a company specializing in the biopharmaceutical products. |  NMS Group NMS Group (Nerviano Medical Sciences) is a company focused on the discovery and early development of oncology drugs. |  Celltrion Healthcare Celltrion Healthcare is a biopharmaceutical company specializing in oncology, influenza, psoriasis, and arthritis., | |
Founding Date | Founding Date 2011 | Founding Date 1994 | Founding Date 2004 | Founding Date N/A | Founding Date 2002 |
Type | Type Subsidiary | Type Public | Type Private | Type Private | Type Public |
Tags | |||||
Locations | Locations Los Angeles, US HQ | Locations Seattle, US HQ | Locations San Diego, US HQ Chengdu Shi, CN Guangzhou Shi, CN Hangzhou, CN Shenzhen Shi, CN Shenzhen Shi, CN Suzhou Shi, CN see more | Locations Nerviano, IT HQ | Locations Incheon, KR HQ |
Employees | Employees 3 | Employees 1968% decrease | Employees 1113% increase | Employees 76 | Employees 6301% increase |
Financial | |||||
Revenue (est.) | Revenue (est.) $24.4m (FY, 2023) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) ₩2t (FY, 2022) |
Cost of goods | Cost of goods $2.8m (FY, 2023) | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods ₩1.4t (FY, 2022) |
Net income | Net income ($65.8m) (FY, 2023) | Net income ($3.4m) (FY, 2025) | Net income N/A | Net income N/A | Net income ₩147.2b (FY, 2022) |
Funding | |||||
Total funding raised | Total funding raised $ 23m | Total funding raised $ 354.8m | Total funding raised $ 12.6m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Omeros
HQ
Seattle, US
Employees
196↓ 8% decrease
Omeros Corporation is a biopharmaceutical company developing products focused on inflammation and central nervous system disorders as well as immune-related diseases, including cancers.
View companyHUYA Bioscience International
HQ
San Diego, US
Employees
111↑ 3% increase
HUYA Bioscience International is a company specializing in the biopharmaceutical products.
View companyNMS Group
HQ
Nerviano, IT
Employees
76
NMS Group (Nerviano Medical Sciences) is a company focused on the discovery and early development of oncology drugs.
View companyCelltrion Healthcare
HQ
Incheon, KR
Employees
630↑ 1% increase
Celltrion Healthcare is a biopharmaceutical company specializing in oncology, influenza, psoriasis, and arthritis.,
View company